Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

0.8471 -0.0149 (-1.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
From Applied DNA Sciences, Inc.
Via Business Wire
CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain
From Flora Growth Corp.
Via Business Wire
Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Announces Third Quarter Fiscal 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues
From Applied DNA Sciences, Inc.
Via Business Wire
FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fiscal 2021 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 13, 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Signs New Contract with U.S. Defense Logistics Agency
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Provides Preliminary Estimated Fiscal Second Quarter 2021 Revenue Range and Business Update
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
From Applied DNA Sciences, Inc. and Takis Biotech/Evvivax
Via Business Wire
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
From Applied DNA Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.